MAAT INDEX

CLAIM #60306 · United Parcel Service Inc (UPS) · 2024Q3 earnings call · Oct 24, 2024 · due Mar 31, 2025

We are targeting to close the Frigo-Trans acquisition in the first quarter of next year.

Carol Tome · CEO

PENDING
graded after results covering Mar 31, 2025 are reported

In context

stomer-first. As we discussed, we have a goal to become the number one complex healthcare logistics provider in the world. To that end, we said we would pursue certain inorganic opportunities and we have. Last month, we entered into an agreement to acquire Frigo-Trans, a move that will enhance our end-to-end temperature-sensitive healthcare capabilities across Europe. Today, 80% of pharmaceuticals in Europe require temperature-controlled transportation. Frigo-Trans offers pan-European cold-chain transportation as well as temperature-controlled and time-critical freight forwarding capabilities. Plus, Frigo-Trans has temperature-controlled warehousing capabilities with every temperature from cryopreservation, which is minus 196 degrees Celsius to ambience, which is about 25 degrees Celsius. We are targeting to close the Frigo-Trans acquisition in the first quarter of next year. Complex healthcare logistics is a growing business for us and we're continuing to invest in the capabilities needed to accelerate growth. We have dedicated healthcare facilities in 36 countries and provide specialized handling and visibility to our customers through our UPS premier product. In the third quarter, we generated $2.5 billion in consolidated healthcare revenue, which contributed to revenue growth across all three segments. Shifting to International. In time for the holidays, we've made several enhancements. In September, we expanded residential Saturday delivery to the eight largest markets in Europe without an additional charge. This enhancement meets our customers' need for speed, and we now provide a superior service offering. Further, we sped up deliveries to over 35 count

Verify independently

SEC filings for UPS · Claim quote is verbatim from the 2024Q3 earnings call.